On March 5, news emerged that Eli Lilly's AI-driven pharmaceutical manufacturing facility, LillyPod, has officially kicked off operations. This marks a historic milestone as it stands as the world's inaugural AI-powered pharmaceutical manufacturing plant to be fully managed by a pharmaceutical firm itself. The factory was rapidly assembled in a mere four months and is outfitted with more than a thousand NVIDIA Blackwell Ultra GPUs, delivering robust computational capabilities to fuel scientific research endeavors.
